Common Contracts

Contract

Option Agreement • May 5th, 2020 • New York

• Contract Type
  Option Agreement
• Filed
  May 5th, 2020
• Jurisdiction
  New York

EX-10.79 3 exhibit1079monsantoamendme.htm EXHIBIT 10.79 Exhibit 10.79 Confidential treatment has been requested for portions of this exhibit. The copy filed herewith omits the information subject to the confidentiality request. Omissions are designated as [***]. A complete version of this exhibit has been filed separately with the Securities and Exchange Commission. AMENDED AND RESTATED PROTIVA AGRICULTURAL DEVELOPMENT COMPANY INC. OPTION AGREEMENT 6503474.12 TABLE OF CONTENTS

Confidential treatment has been requested for portions of this exhibit. The copy filed herewith omits the information subject to the confidentiality request. Omissions are designated as [***]. A complete version of this exhibit has been filed...

Option Agreement • March 9th, 2016 • Arbutus Biopharma Corp • Pharmaceutical preparations • New York

• Contract Type
  Option Agreement
• Filed
  March 9th, 2016
• Company
  Arbutus Biopharma Corp
• Industry
  Pharmaceutical preparations
• Jurisdiction
  New York

This AMENDED AND RESTATED OPTION AGREEMENT (this “Agreement”), made as of March 4, 2016 (the “Effective Date”) by and among Monsanto Canada, Inc., a Canadian corporation (“Monsanto Canada”), Arbutus Biopharma Corporation (formerly known as Tekmira Pharmaceuticals Corporation), a British Columbia corporation (“Arbutus”), Protiva Biotherapeutics Inc., a British Columbia corporation (“Protiva”), and Protiva Agricultural Development Company Inc., a British Columbia corporation (the “Company”).